These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16899174)

  • 1. Collaborated basic bio-medical research.
    Farooq S
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):499-500. PubMed ID: 16899174
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ
    J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 6. Need for a new framework to understand the mechanism of all antipsychotics.
    Stip E; Liddle PF; Soucy JP
    J Clin Psychiatry; 2000 May; 61(5):387-8. PubMed ID: 10847316
    [No Abstract]   [Full Text] [Related]  

  • 7. Presynaptic receptors for dopamine, histamine, and serotonin.
    Feuerstein TJ
    Handb Exp Pharmacol; 2008; (184):289-338. PubMed ID: 18064418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monoamine research--a productive field of particular importance in neuroscience].
    Carlsson A
    Lakartidningen; 1990 Nov; 87(45):3764, 3767-9. PubMed ID: 1977976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.
    Borison RL; Hitri A; Blowers AJ; Diamond BI
    Clin Neuropharmacol; 1983 Jun; 6(2):137-50. PubMed ID: 6133618
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 14. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study shows newer schizophrenia treatments no more effective than old.
    Frantz S
    Nat Rev Drug Discov; 2005 Nov; 4(11):872-3. PubMed ID: 16299914
    [No Abstract]   [Full Text] [Related]  

  • 16. [Etiology of schizophrenia: neurochemical aspects].
    de las Cuevas Castresana C; González de Rivera JL
    Neurologia; 1994 Feb; 9(2):54-9. PubMed ID: 7515627
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia.
    Werkman TR; Glennon JC; Wadman WJ; McCreary AC
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):3-23. PubMed ID: 16613551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antipsychotic drugs. Pharmacology, therapeutic effect and adverse effects].
    Gerlach J
    Ugeskr Laeger; 1992 Feb; 154(9):548-54. PubMed ID: 1347186
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonergic approaches in the development of novel antipsychotics.
    Jones CA; McCreary AC
    Neuropharmacology; 2008 Nov; 55(6):1056-65. PubMed ID: 18621404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors, antipsychotic action and schizophrenia.
    Reynolds GP
    J Psychopharmacol; 1999; 13(2):202-3. PubMed ID: 10475731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.